New patient-centric website launched in Europe to empower people with chronic conditions

Teva Pharmaceutical Industries Ltd. today announced the European launch of Life Effects (, a patient-centric website hosting content created by patients and checked by experts, at the European Committee for the Treatment and Research of Multiple Sclerosis (ECTRIMS) Congress in Berlin. This online content initiative was created following extensive research from 13,500 patients globally and is now being launched in Europe. Research shows a demand from patients especially those with chronic conditions including Multiple Sclerosis (MS), for trustworthy and reliable health information.

Read More on The Medical News